Cardiol Therapeutics (CRDL) Intangibles (2020 - 2024)
Cardiol Therapeutics (CRDL) posted Intangibles of $549219.5 for Q4 2024, up 346.77% on a QoQ basis from $122931.0 in Q2 2024, and up 255.45% year-over-year from $154515.4 in Q1 2024.
Cardiol Therapeutics (CRDL) Intangibles (2020 - 2024) Analysis & Trends
Cardiol Therapeutics' Intangibles history runs 5 years deep, the most recent figure standing at $549219.5 for Q4 2024.
- Quarterly Intangibles rose 255.45% year-over-year to $549219.5 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $549219.5 (up 255.45% YoY) and the FY2024 annual result came in at $549219.5, up 255.45% from the prior year.
- Intangibles was $549219.5 for Q4 2024 at Cardiol Therapeutics, up from $122931.0 in the prior quarter.
- Across five years, Intangibles topped out at $588505.8 in Q4 2020 and bottomed at -$307800.1 in Q4 2021.
- A 5-year average of $231891.1 and a median of $217181.5 in 2022 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2021 — Intangibles sank 152.3% — and 2024, when it soared 255.45%.
- Cardiol Therapeutics' Intangibles stood at $588505.8 in 2020, then plunged by 152.3% to -$307800.1 in 2021, then soared by 170.56% to $217181.5 in 2022, then decreased by 28.85% to $154515.4 in 2023, then surged by 255.45% to $549219.5 in 2024.
- Business Quant data shows CRDL's Intangibles at $549219.5 in Q4 2024, $122931.0 in Q2 2024, and $140442.7 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 549,219.50 |
| Jun 30, 2024 | 122,931.05 |
| Mar 31, 2024 | 140,442.70 |
| Dec 31, 2023 | 154,515.42 |
| Sep 30, 2023 | 172,659.78 |
| Jun 30, 2023 | 188,033.80 |
| Mar 31, 2023 | 202,448.24 |
| Dec 31, 2022 | 217,181.50 |
| Sep 30, 2022 | 242,225.11 |
| Jun 30, 2022 | 264,341.62 |
| Mar 31, 2022 | 282,738.77 |
| Dec 31, 2021 | -307,800.12 |
| Sep 30, 2021 | 318,047.33 |
| Jun 30, 2021 | 342,875.66 |
| Dec 31, 2020 | 588,505.82 |